( cerebrovascular orPAD but who have a...)REACH Registry Demonstrates That Multiple Arterial Disease,Locations Sharply Increase the Risk of Major CV Events in,Outpatients With Atherothrombosis,Health

"I find these event rates to be high, given that we are dealing with a stable outpatient population treated with contemporary therapy," said Dr Gabriel Steg, professor of cardiology at Hopital Bichat-Claude Bernard, Paris, on behalf of the REACH Registry's Scientific Council. "The impact of polyvascular disease on the risk of event in REACH shows that it is critical that we stop viewing atherothrombosis as a disease of a specific medical specialty - cardiology, neurology, or vascular disease - instead we must view it as a 'global' disease, Doctors' adherence to evidence-based guidelines for treatment are important to manage the risk for this group of patients" Dr. Steg said.

Objectives and scope of REACH

The overall aim of the REACH registry is to improve the assessment and management of stroke, heart attack and associated risk factors for atherothrombosis. It is the largest and most geographically extensive global registry of patients at risk of atherothrombosis, having recruited over 68,000 patients in 44 countries, covering six regions - Latin America, Asia, the Middle East, Australia, Europe and North America - and involving over 5,000 physician investigators.

The REACH Registry includes a broad spectrum of patients with atherothrombosis - documenting the health status and treatment of people at risk of atherothrombosis; monitoring how they are affected; and measuring the burden of the disease. Patients included in the REACH Registry either have several of the risk factors that can lead to atherothrombosis, such as, high cholesterol, high blood pressure, smoking, and diabetes, or have a previous history of heart attack, stroke or PAD. Participation in the REACH Registry is strictly voluntary.

In
'"/>